title: Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.
authors.forename: Colm
authors.initials: C
authors.lastname: Keane
authors.forename: Peter
authors.initials: P
authors.lastname: Mollee
authors.forename: Paula
authors.initials: P
authors.lastname: Marlton
authors.forename: Devinder
authors.initials: D
authors.lastname: Gill
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D004921:Erythropoietin / Q000008:administration & dosage; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D033221:Jehovah's Witnesses; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000188:drug therapy / Q000523:psychology; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D012074:Remission Induction; D016896:Treatment Outcome; D014212:Tretinoin / Q000008:administration & dosage*
chemical_list: D006454:Hemoglobins; D003561:Cytarabine; D004921:Erythropoietin; D014212:Tretinoin; D015122:Mercaptopurine; D008727:Methotrexate